Search results for "34"

showing 10 items of 1830 documents

Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome

2019

We present a case of posterior reversible encephalopathy syndrome with severe clinical manifestation. Apart from initial aphasia, hemiparesis, and a generalized seizure, the patient had a prolonged loss of consciousness. Although blood pressure was normalized, the clinical status deteriorated continuously. After adding steroids to the therapy, the patient recovered rapidly, suggesting that this could have been a useful therapeutic approach. Even the vasogenic edema in the cerebral magnetic resonance imaging disappeared shortly within 6 days.

medicine.medical_specialtyEncephalopathyPATHOPHYSIOLOGYCase ReportEncephalopathylcsh:RC346-42903 medical and health sciencesTherapeutic approach0302 clinical medicineInternal medicineAphasiamedicineMANAGEMENT030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemSPECTRUMmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingPosterior reversible encephalopathy syndromeEDEMAmedicine.diseaseBlood pressureHemiparesisPosterior reversible encephalopathy syndromeCardiologyEncephalitisNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryEncephalitis
researchProduct

The assessment of vertebral fractures in elderly women with recent hip fractures: the BREAK Study

2012

This study aimed to evaluate the prevalence of vertebral fractures in elderly women with a recent hip fracture. The burden of vertebral fractures expressed by the Spinal Deformity Index (SDI) is more strictly associated with the trochanteric than the cervical localization of hip fracture and may influence short-term functional outcomes. INTRODUCTION: This study aimed to determine the prevalence and severity of vertebral fractures in elderly women with recent hip fracture and to assess whether the burden of vertebral fractures may be differently associated with trochanteric hip fractures with respect to cervical hip fractures. METHODS: We studied 689 Italian women aged 60 years or over with …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismOsteoporosisDentistryWalkingelderlySeverity of Illness Indexvertebral fracture; hip fracture; elderly; osteoporosis; burdenThoracic VertebraeburdenHip fractureInternal medicinemedicinePrevalenceHumansLife StyleSpinal deformity indexCervical fractureTrochanteric fractureAgedAged 80 and overHip fractureLumbar VertebraeCervical fracturebusiness.industryHip FracturesSettore MED/34 - Medicina Fisica E RiabilitativaMiddle Agedmedicine.diseaseosteoporosisRheumatologyRadiographyItalyOrthopedic surgerycervical fracutre hip fracture spinal deformity index trochanteric fracture vertebral fractureSpinal deformitySpinal FracturesFemaleVertebral fracturebusinessOsteoporotic Fractures
researchProduct

Can Ketogenic Diet Improve Alzheimer's Disease? Association With Anxiety, Depression, and Glutamate System

2021

Background: Alzheimer's disease is the most common neurodegenerative disorder in our society, mainly characterized by loss of cognitive function. However, other symptoms such as anxiety and depression have been described in patients. The process is mediated by alterations in the synaptic and extrasynaptic activity of the neurotransmitter glutamate, which are linked to a hypometabolism of glucose as the main source of brain energy. In that respect, Ketogenic diet (KD) has been proposed as a non-pharmacological treatment serving as an alternative energy source to the neurons increasing the fat percentage and reducing the carbohydrates percentage, showing promising results to improve the cogni…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentketogenic dietsglutamateDiseaseNeurotransmissionchemistry.chemical_compoundInternal medicinemedicineTX341-641NeurotransmitterDepression (differential diagnoses)NutritionNutrition and Dieteticsbusiness.industryNutrition. Foods and food supplyGlutamate receptorCognitionAlzheimer's diseaseanxietyEndocrinologychemistryPerspectivedepressionAnxietymedicine.symptombusinessFood ScienceKetogenic dietFrontiers in Nutrition
researchProduct

Ingesta nutricional en pacientes afectados de esclerosis lateral amiotrófica una consulta ambulatoria de nutrición artificial en Portugal

2021

Introducción: La Esclerosis Lateral Amiotrófica (ELA) es una patología neurodegenerativa crónica y progresiva, que produce la muerte de las motoneuronas. Deriva en pérdida de peso, de masa muscular e incremento de deficiencias nutricionales. Existe relación entre la ingesta nutricional y la patogénesis de la ELA. El objetivo de este análisis fue describir las características sociodemográficas, antropométricas y clínicas junto con la ingesta nutricional en una muestra de pacientes portugueses afectados de ELA. Material y Métodos: Se realizó una anamnesis clínica breve. El peso corporal fue evaluado siguiendo el protocolo de la International Society for the Advancement of Kinanthropometry (IS…

medicine.medical_specialtyEsclerosis Amiotrófica LateralRC620-627ConstipationAntioxidantesWeight lossInternal medicinemedicineVitamin D and neurologyTX341-641Amyotrophic lateral sclerosisEstado NutricionalNutritional diseases. Deficiency diseasesAnamnesisNutrition and DieteticsPortugalNutrition. Foods and food supplybusiness.industryIngestión de AlimentosAnthropometrymedicine.diseaseMalnutritionDietary Reference Intakemedicine.symptombusinessFood ScienceRevista Española de Nutrición Humana y Dietética
researchProduct

Isolated Dysphagia in a Patient with Medial Medullary Infarction – Effects of Evidence-Based Dysphagia Therapy: A Case Report

2021

Medial medullary infarction (MMI) is a vascular occlusion in the medulla oblongata leading to certain constellations of neurological symptoms and seriously affecting the patient. Effective evidence-based treatment of severe dysphagia as sole symptom of MMI has not yet been reported. This case study aims to report successful effects of evidence-based therapy based on findings of dysphagia symptoms and pathophysiology of swallowing by flexible endoscopic evaluation of swallowing (FEES) in severe isolated dysphagia after MMI. FEES was performed to evaluate swallowing pathophysiology and dysphagia symptoms in a 57-year-old male with severe dysphagia after MMI. On the basis of FEES findings, sim…

medicine.medical_specialtyEvidence-based practiceMedullary cavitydysphagiamedicine.medical_treatmentInfarctionVascular occlusionlcsh:RC346-429Swallowingflexible endoscopic evaluation of swallowingotorhinolaryngologic diseasesmedicinecase reportmedial medullary infarctionlcsh:Neurology. Diseases of the nervous systemRehabilitationbusiness.industryevidence-based therapyCase Series − General Neurologymedicine.diseaseDysphagiaPathophysiologySurgerydysphagia therapyNeurology (clinical)medicine.symptombusinessCase Reports in Neurology
researchProduct

Event-related potentials to task-irrelevant changes in facial expressions

2009

Abstract Background Numerous previous experiments have used oddball paradigm to study change detection. This paradigm is applied here to study change detection of facial expressions in a context which demands abstraction of the emotional expression-related facial features among other changing facial features. Methods Event-related potentials (ERPs) were recorded in adult humans engaged in a demanding auditory task. In an oddball paradigm, repeated pictures of faces with a neutral expression ('standard', p = .9) were rarely replaced by pictures with a fearful ('fearful deviant', p = .05) or happy ('happy deviant', p = .05) expression. Importantly, facial identities changed from picture to pi…

medicine.medical_specialtyFacial expressiongenetic structuresPsykologia - PsychologyCognitive NeuroscienceResearchMismatch negativityContext (language use)General MedicineAudiologybehavioral disciplines and activitieslcsh:RC346-429Expression (mathematics)Behavioral NeuroscienceStimulus modalityEvent-related potentialmental disordersmedicinePsychologyOddball paradigmNeurosciencelcsh:Neurology. Diseases of the nervous systemChange detectionBiological PsychiatryBehavioral and Brain Functions : BBF
researchProduct

The reconstructive role of TachoSil in neurosurgery

2016

Abstract Hemorrhages, cerebrospinal fluid (CSF) fistula and infections are the most challenging post-operative complications in Neurosurgery [1–5]. Fibrin sealant agents have been developed with the aim to provide efficient hemostasis and safe dural closure [3,6–14]. In this study we report our initial experience using TachoSil® (haemostatic surgical patch; Nycomed, Linz, Austria) in achieving hemostasis and CSF leakage repair during cranio-cerebral procedures [15–18]. We describe and show the unique features of this fibrin sealant, pioneered with stunning success in many surgical procedures known to be at high risk of peri- and postoperative bleeding (i.e. nephrectomies, pulmonary lobectom…

medicine.medical_specialtyFistulalcsh:Surgery030204 cardiovascular system & hematologylcsh:RC346-429Fibrin03 medical and health sciences0302 clinical medicineMedicineCsf leakagelcsh:Neurology. Diseases of the nervous systembiologySettore MED/27 - Neurochirurgiabusiness.industrylcsh:RD1-811TachoSilSurgical proceduresmedicine.diseaseTachosilSurgeryHemostasisbiology.proteinSurgeryDural closureNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryInterdisciplinary Neurosurgery
researchProduct

Improvement of quality of life during treatment with anabolic therapy: Results of a multicenter study

2012

Efficacy and safety of daily treatment with parathyroid hormone were evaluated in a typical Italian population with severe post-menopausal osteoporosis eligible to anabolic treatment (Nota 79 AIFA). Materials and methods: 204 ambulatory female patients (median age: 72.6±8.3 years; height: 155.3±6.5 cm; weight: 61.1±11.9 Kg) with severe post-menopausal osteoporosis have been enrolled in this study accordingly to summary of product characteristics and Italian reimbursement criteria for osteoporosis drugs (Nota 79 AIFA), between January 2008 and April 2009 (Last Patient Out: October 2010). 146 (71.57%) out of these patients completed the study.6 visits were planned in the study protocol: basel…

medicine.medical_specialtyHistologyAnabolismosteoporosis PTH Qualeffo QolPhysiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaEndocrinology Diabetes and MetabolismQuality of life (healthcare)Multicenter studymedicineIntensive care medicinebusinessBone
researchProduct

Effect of the Alterations in Contractility and Morphology Produced by Atrial Fibrillation on the Thrombosis Potential of the Left Atrial Appendage

2021

Atrial fibrillation (AF) is a common arrhythmia mainly affecting the elderly population, which can lead to serious complications such as stroke, ischaemic attack and vascular dementia. These problems are caused by thrombi which mostly originate in the left atrial appendage (LAA), a small muscular sac protruding from left atrium. The abnormal heart rhythm associated with AF results in alterations in the heart muscle contractions and in some reshaping of the cardiac chambers. This study aims to verify if and how these physiological changes can establish hemodynamic conditions in the LAA promoting thrombus formation, by means of computational fluid dynamic (CFD) analyses. In particular, sinus …

medicine.medical_specialtyHistologythromboembolic eventleft atrial appendagelcsh:Biotechnology0206 medical engineeringBiomedical EngineeringThrombogenicityHemodynamicsBioengineering02 engineering and technology030204 cardiovascular system & hematologyContractilitySettore ING-IND/14 - Progettazione Meccanica E Costruzione Di Macchine03 medical and health sciencescomputational fluid dynamic0302 clinical medicinecardiac wall motionInternal medicinelcsh:TP248.13-248.65Medicineatrial fibrillationThrombusStrokeOriginal ResearchFibrillationbusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeBioengineering and BiotechnologyAtrial fibrillationmedicine.disease020601 biomedical engineeringThrombosisCardiologymedicine.symptombusinessBiotechnologyFrontiers in Bioengineering and Biotechnology
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct